Implicity, founded in 2016 by cardiac electrophysiologist Arnaud Rosier MD, is a pioneering digital MedTech company headquartered in France. Specializing in AI Cardiac Remote Monitoring, the company provides an innovative platform for hospitals and clinics that facilitates exceptional remote care for cardiac patients.
The company’s platform employs unique AI-driven and knowledge-based algorithms to predict patient health status, significantly reducing the workload of healthcare professionals. By aggregating, normalizing, and standardizing data from all implantable cardiac electronic devices—regardless of the manufacturer—Implicity enhances care for patients with chronic heart failure conditions.
Currently, the platform safeguards over 100,000 patients in more than 250 medical facilities across the United States and Europe. Recently, the company secured a €35.00M investment at the Series Unknown stage, with backing from investors IRIS and Five Arrows. This funding is set to propel Implicity in its quest to revolutionize cardiac care.